Spirometry interpretation, asthma/COPD severity, oxygenation indices, and pulmonary embolism scoring.
Assesses degree of shunt and ventilation/perfusion (V/Q) mismatch through the alveolar-arterial oxygen gradient
Validates asthma control in patients 12 years and older by assessing both symptom impairment and exacerbation risk domains
A-a gradient to evaluate hypoxemia mechanism.
Assess asthma control over the past 4 weeks (ages 12+).
Predicts mortality in acute COPD exacerbation using BUN, Altered mental status, Pulse rate, and age ≥65 years
Provides diagnostic criteria for acute respiratory distress syndrome (ARDS) and classifies severity based on oxygenation
Screen for obstructive sleep apnea risk (3 categories).
Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.
Predicts 30-day risk of PE-related complications (death, hemodynamic collapse, or recurrent PE) in hemodynamically stable patients with confirmed pulmonary embolism
COPD Assessment Test: impact of COPD on daily life.
Asthma control assessment for children aged 4-11 (child + caregiver).
Closing capacity = closing volume + residual volume.
CC/TLC ratio as percent.
CV/VC ratio as percent.
Quantifies the impact of COPD symptoms on patients' overall health and quality of life. The CAT is a patient-completed questionnaire that assesses multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality.
Evaluates objective data in mechanically ventilated patients suspected of ventilator-associated pneumonia (VAP) and stratifies risk of positive diagnosis. The score assists clinicians in determining when to pursue pulmonary cultures and guides antibiotic management decisions.
Stratifies severity of community-acquired pneumonia (CAP) to determine outpatient versus inpatient treatment using 4 clinical criteria (without blood urea nitrogen)
Assesses the severity of community-acquired pneumonia (CAP) to determine the need for hospital admission
Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.
Adjusts diffusing capacity (DLCO) for hemoglobin concentration (Cotes equation).
Determines 1-year mortality risk in IPF patients using PFT and clinical indicators. Developed from two clinical trials (n=1,099) to identify independent predictors of 1-year mortality in idiopathic pulmonary fibrosis.
Measure daytime sleepiness; screens for sleep disorders.
Estimates expected peak expiratory flow rate and quantifies asthma exacerbation severity based on age, height, race, and sex.
Provides guidelines for management of solid and subsolid pulmonary nodules detected incidentally on CT
Clinical probability score for suspected pulmonary embolism using 13 clinical variables to safely decrease imaging testing needs
ECSC reference equations for predicted FRC.
Provides 1, 2, and 3-year mortality estimates for IPF patients. The GAP Index uses Gender, Age, and Physiology (FVC and DLCO) to predict mortality risk and guide clinical management decisions.
Objectifies risk of pulmonary embolism, similar to Wells' score, but without requiring clinical gestalt. Helps determine clinical probability of PE to guide diagnostic workup including D-dimer testing and imaging decisions
Clinical assessment and staging system for chronic obstructive pulmonary disease (COPD) based on spirometry, symptoms, and exacerbation risk. Provides comprehensive evaluation using FEV1 percentage predicted, symptom assessment, and treatment recommendations according to GOLD 2024-2025 guidelines.
Assesses lung function, particularly in intubated patients, by calculating the ratio of arterial oxygen partial pressure to fraction of inspired oxygen. Also known as the P/F ratio or Carrico index.
Determines if pleural fluid is exudative or transudative by comparing pleural fluid and serum protein and LDH levels
Predicts 2-year survival in patients with small cell lung cancer (SCLC) using six clinical and laboratory parameters. Stratifies patients into three prognostic groups (good, medium, poor) to guide treatment decisions and clinical management.
Stratifies severity of dyspnea in respiratory diseases, particularly COPD, based on functional disability
Predicts 90-day mortality risk in patients with viral pneumonia using clinical and laboratory parameters to guide treatment decisions and resource allocation.
Stratifies severity of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), and is also used for patient selection for extracorporeal membrane oxygenation (ECMO). The Murray Score provides objective assessment of lung injury severity using four physiological parameters.
NoSAS score for sleep-disordered breathing screening (Marti-Soler 2016): neck circumference, BMI, snoring, age, sex; total 0-17. Score ≥8 = high risk.
Percent predicted FEV1 = (measured FEV1 / predicted FEV1) × 100, using a reference (e.g. GLI) predicted value. GOLD airflow-limitation bands: ≥80 mild, 50-79 moderate, 30-49 severe, <30 very severe.
Light index estimates pneumothorax size from chest radiograph diameters.
Estimates postoperative FEV1 after lung resection by anatomic segment counting (19 total segments).
Estimates postoperative FEV1 using quantitative perfusion scan of the lung to be resected.
Weaning predictor: respiratory rate divided by tidal volume in liters. < 105 predicts successful weaning.
RV/TLC ratio; elevation suggests air trapping / hyperinflation.
PE mortality risk: 0 = low (~1%), >=1 = high (~9%).
Enright reference equations for predicted 6-minute walk distance.
Community-acquired pneumonia severity (SMART-COP without albumin/pH): 0-8.
Screens for obstructive sleep apnea (OSA) risk using 8 binary criteria. Each positive item scores 1 point (0-8).
STOP-Bang questionnaire (Chung): 8-item screening tool for obstructive sleep apnea (OSA). One point per positive item (snoring, tiredness, observed apnea, hypertension, BMI >35, age >50, neck >40 cm, male). Score 0-8 stratifies OSA risk.
Thoracoscore (Falcoz 2007): logistic-regression risk model predicting in-hospital mortality after general thoracic surgery from 9 preoperative variables. Logit = -7.3737 + Σβ; predicted mortality = e^logit / (1 + e^logit).
Total lung capacity (TLC) as the sum of the four lung volumes: inspiratory reserve volume + tidal volume + expiratory reserve volume + residual volume. Standard pulmonary physiology definition.
Vital capacity (VC): the maximum volume of air exhaled after a maximum inhalation, as the sum of inspiratory reserve volume + tidal volume + expiratory reserve volume (VC = IRV + TV + ERV).
Clinical pretest probability score for pulmonary embolism based on seven bedside criteria; supports both 3-tier (low/intermediate/high) and 2-tier (PE unlikely/likely) interpretations to guide D-dimer testing and imaging decisions
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.